Will Telehealth Stocks Thrive After COVID?
When COVID-19 shut down the world economy last year, a lot of basic healthcare moved to the internet. Many doctors and patients avoided in-person meetings and met online. Not surprisingly, revenue took off for many virtual players, and the stocks followed suit. And the trend has shown no signs of abating. For instance, industry bellwether Teladoc Health reported 108% revenue growth in its most recent quarter. That's dramatic revenue growth on top of the outstanding growth Teladoc had last year, when the pandemic was raging and doctor's offices were shut down.
What does the future hold for the rest of this sector? Three Fool contributors are bullish on Doximity (NYSE: DOCS), Teladoc competitor American Well (NYSE: AMWL), and small-cap name UpHealth (NYSE: UPH), even after the pandemic ends.
Image source: Getty Images.
Source Fool.com
